1. Survival analysis of extramammary Paget’s disease (EMPD) in a tertiary hospital in Taiwan
- Author
-
Yu-Wei Chang, Wen-Chieh Liao, and Hsu Ma
- Subjects
Adult ,Male ,medicine.medical_specialty ,RD1-811 ,Population ,Taiwan ,Malignancy ,Extramammary Paget's disease ,Metastasis wide excision ,Metastasis ,Tertiary Care Centers ,030207 dermatology & venereal diseases ,03 medical and health sciences ,0302 clinical medicine ,Surgical oncology ,Internal medicine ,medicine ,Clinical endpoint ,Humans ,Extramammary Paget disease (EMPD) ,education ,Survival analysis ,RC254-282 ,Aged ,Retrospective Studies ,Aged, 80 and over ,education.field_of_study ,business.industry ,Research ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,Middle Aged ,Prognosis ,medicine.disease ,Confidence interval ,Paget Disease, Extramammary ,Oncology ,030220 oncology & carcinogenesis ,Female ,Surgery ,Neoplasm Recurrence, Local ,business - Abstract
Background This study aimed to investigate the survival analysis of extramammary Paget’s disease (EMPD) in a Taiwanese population and to provide data for comparison with other studies in various locations and racial populations. Methods We retrospectively analyzed the medical records of 63 patients with EMPD who were surgically treated from 2002 to 2019 at a single institution. The primary endpoint was the 5-year overall survival rate of EMPD, and the secondary endpoint was recurrence-free 5-year survival. Independent variables included patients’ demographic data, concurrent malignancy (i.e., non-EMPD-related cancers), tumor size, distant metastasis, and surgery and/or radiation. Results Of all the 63 patients, 8 cases were excluded. A total of 43 patients (78.18%) were male, and 12 were female, with a mean age of 72.67 years (range 44–89 years). The most common affected anatomic site was the penoscrotal region (22 patients, 40.00%), followed by the perianal and perineal regions (17 patients, 30.91%). Among the 55 patients, 41 patients (74.55%) were diagnosed with at least one underlying disease, whereas the most common underlying disease was cardiovascular disease (30 patients, 54.55%). The overall survival rate was 80.00% at 36 months and 65.45% at the end of follow-up. EMPD with deep dermal invasion was a significant poor prognostic factor of overall survival in cause-specific hazard model (sub-hazard ratio (HR) 5.167, p = 0.0015, 95% confidence interval (CI) 1.876–14.230). Patients with regional metastasis or distant metastasis had poorer prognosis of 5-year survival (sub-HR 4.513, p = 0.0028, CI 1.683–12.103). The limitations of this study include its retrospective nature and sample size. Conclusions In our series, EMPD with metastasis and deep dermal invasion was the significant harmful factors in both overall 5-year survival and 5-year recurrence-free survival. The surgical excision is not associated with a low risk of local recurrence or overall survival, and long-term follow-up is still needed.
- Published
- 2021